Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
26.71
Dollar change
+1.39
Percentage change
5.49
%
IndexRUT P/E- EPS (ttm)-1.76 Insider Own12.25% Shs Outstand82.56M Perf Week-2.41%
Market Cap2.33B Forward P/E- EPS next Y-4.81 Insider Trans-2.05% Shs Float72.66M Perf Month0.34%
Income-143.59M PEG- EPS next Q-1.27 Inst Own81.95% Short Float16.47% Perf Quarter14.15%
Sales349.64M P/S6.67 EPS this Y-174.55% Inst Trans5.98% Short Ratio12.01 Perf Half Y15.08%
Book/sh9.58 P/B2.79 EPS next Y-1.85% ROA-11.67% Short Interest11.97M Perf Year-6.84%
Cash/sh10.60 P/C2.52 EPS next 5Y-3.70% ROE-18.29% 52W Range20.84 - 49.50 Perf YTD-1.87%
Dividend Est.- P/FCF- EPS past 5Y5.58% ROI-15.27% 52W High-46.04% Beta1.91
Dividend TTM- Quick Ratio5.69 Sales past 5Y43297.50% Gross Margin93.75% 52W Low28.17% ATR (14)1.81
Dividend Ex-DateFeb 04, 2014 Current Ratio5.69 EPS Y/Y TTM58.80% Oper. Margin-52.25% RSI (14)53.74 Volatility6.60% 7.45%
Employees436 Debt/Eq0.20 Sales Y/Y TTM328.73% Profit Margin-41.07% Recom1.89 Target Price49.20
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q3.53% Payout- Rel Volume1.03 Prev Close25.32
Sales Surprise-1.70% EPS Surprise1.12% Sales Q/Q-17.01% EarningsNov 05 BMO Avg Volume996.01K Price26.71
SMA201.73% SMA507.91% SMA2000.75% Trades Volume1,030,100 Change5.49%
Date Action Analyst Rating Change Price Target Change
Nov-06-24Upgrade Leerink Partners Market Perform → Outperform $27 → $39
Oct-16-24Initiated Scotiabank Sector Outperform
Jul-23-24Initiated H.C. Wainwright Buy $80
Jan-29-24Upgrade JP Morgan Neutral → Overweight $38 → $40
Dec-15-23Downgrade BofA Securities Buy → Neutral $35
Dec-08-23Downgrade Jefferies Buy → Hold $75 → $30
Oct-20-23Downgrade Leerink Partners Outperform → Market Perform $75 → $20
Oct-20-23Downgrade Cantor Fitzgerald Overweight → Neutral
Mar-21-23Initiated Bernstein Mkt Perform $37
Feb-01-23Initiated Cantor Fitzgerald Overweight $62
Dec-08-24 01:45PM
Dec-07-24 11:30AM
Dec-06-24 07:00AM
Dec-05-24 11:30AM
Dec-04-24 07:00AM
04:01PM Loading…
Nov-12-24 04:01PM
Nov-07-24 06:26AM
Nov-06-24 02:12AM
01:40AM
Nov-05-24 03:37PM
09:00AM
07:40AM
06:30AM
04:18AM
Oct-31-24 03:50AM
06:30AM Loading…
Oct-29-24 06:30AM
Oct-23-24 08:47AM
Oct-17-24 03:05PM
Sep-05-24 11:31AM
Aug-14-24 10:27AM
Aug-09-24 10:19AM
Aug-07-24 10:50AM
Aug-06-24 01:54PM
07:45AM
06:30AM
Jul-26-24 07:43AM
Jul-24-24 06:28PM
08:53AM
08:23AM
Jul-22-24 04:45PM
07:45AM Loading…
Jul-17-24 07:45AM
Jul-16-24 10:12AM
Jul-15-24 06:30AM
Jul-11-24 12:56PM
Jul-09-24 12:00PM
07:00AM
06:25AM
Jul-04-24 02:13PM
Jul-03-24 09:12AM
Jun-27-24 10:02PM
10:26AM
Jun-26-24 06:30AM
Jun-14-24 03:00AM
Jun-06-24 11:31AM
May-30-24 06:30AM
May-14-24 04:00PM
May-13-24 02:18PM
May-09-24 06:49AM
May-08-24 10:52AM
06:30AM
May-07-24 09:02PM
01:54PM
10:17AM
06:30AM
May-01-24 10:01AM
Mar-28-24 11:30AM
Mar-26-24 06:30AM
Feb-28-24 06:30AM
Feb-27-24 04:01PM
02:57PM
12:33PM
07:11AM
06:30AM
Feb-20-24 10:00AM
Feb-16-24 02:46PM
Feb-10-24 05:09PM
Feb-07-24 07:35AM
Feb-05-24 06:30AM
Jan-29-24 06:21PM
Jan-16-24 01:51PM
09:00AM
Jan-11-24 04:38PM
Jan-08-24 06:30AM
05:52AM
Jan-02-24 06:30AM
Dec-27-23 10:30AM
Dec-15-23 10:22AM
Dec-14-23 06:30AM
Dec-08-23 11:30AM
Nov-30-23 09:55AM
Nov-23-23 11:03AM
09:42AM
Nov-20-23 05:43PM
Nov-18-23 07:15AM
06:49AM
Nov-17-23 12:00PM
Nov-14-23 05:50AM
Nov-10-23 09:55AM
Nov-09-23 01:04PM
Nov-08-23 06:30AM
06:30AM
Nov-06-23 08:02AM
Nov-05-23 08:30AM
Nov-01-23 05:40AM
Oct-31-23 07:09PM
04:04PM
10:01AM
10:00AM
06:00AM
05:00AM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ciaramella GiuseppePresidentNov 06 '24Sale26.3651,1101,347,050109,150Nov 08 04:10 PM
Ciaramella GiuseppePresidentOct 14 '24Option Exercise2.0041,75483,594211,370Oct 16 04:44 PM
Ciaramella GiuseppePresidentOct 14 '24Sale26.2751,1101,342,752160,260Oct 16 04:44 PM
Giuseppe CiaramellaOfficerOct 14 '24Proposed Sale24.65102,2202,519,723Oct 15 11:37 AM
Burrell Terry-AnnOfficerOct 07 '24Proposed Sale23.00185,5654,267,995Oct 07 05:00 PM
Bellon ChristineChief Legal OfficerOct 01 '24Sale23.483859,040104,209Oct 02 05:52 PM
Cavanagh Bethany JSVP, Finance and TreasurerOct 01 '24Sale23.482896,78544,931Oct 02 05:51 PM
Evans John M.CEOSep 30 '24Sale24.6060,0001,476,024938,659Oct 02 05:49 PM
JOHN M EVANSOfficerSep 30 '24Proposed Sale24.6060,0001,476,024Sep 30 04:51 PM
Simon AmyChief Medical OfficerJul 02 '24Sale22.9574817,16768,805Jul 03 04:05 PM
Simon AmyChief Medical OfficerJul 01 '24Sale23.7650211,92869,553Jul 03 04:05 PM
Evans John M.CEOJun 27 '24Sale24.5060,0001,470,156998,343Jun 28 04:15 PM
Simon AmyChief Medical OfficerApr 02 '24Sale30.5416,530504,85170,060Apr 03 07:43 PM
Simon AmyChief Medical OfficerApr 01 '24Sale32.137,157229,95486,590Apr 03 07:43 PM
Bellon ChristineChief Legal OfficerApr 01 '24Sale32.123,401109,240104,594Apr 03 07:40 PM
Burrell Terry-AnnChief Financial OfficerApr 01 '24Sale32.125,446174,92670,137Apr 03 07:39 PM
Evans John M.CEOApr 01 '24Sale32.1318,102581,6171,058,343Apr 03 07:36 PM
Ciaramella GiuseppePresidentApr 01 '24Sale32.124,534145,632169,616Apr 03 07:33 PM
Evans John M.CEOMar 28 '24Sale33.8660,0002,031,402998,262Apr 01 04:10 PM
FMR LLCSee Remark 1Feb 14 '24Sale30.55900,00027,496,9121,235,511Feb 15 02:34 PM
FMR LLCSee Remark 1Feb 13 '24Sale30.761,56548,1392,771,913Feb 15 02:34 PM
Evans John M.CEOJan 31 '24Sale25.3360,0001,519,8001,058,262Feb 02 04:05 PM
Bellon ChristineChief Legal OfficerJan 03 '24Sale26.421,90750,38380,495Jan 05 04:30 PM